文献速递老年与多病共存慢病管理

全科药师优化老年多病共存多重用药管理的系统综述

A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy.
PubMed 文献 · Fam Pract · 2021-01-01

该系统综述检索8个电子数据库和3个试验注册库至2020年4月,纳入7项研究,评估全科诊所药师(PBP)单独或协作优化≥65岁多病共存且多重用药患者药物管理服务的类型与效果。所有纳入研究均采用PBP主导的药物审查并由全科医生同意实施建议,有限证据显示混合效果,多数研究质量较差。

要点

  • PBP主导药物审查并联合全科医生实施建议是纳入研究中的主要服务模式。
  • 有限证据显示PBP干预对优化老年多病共存多重用药管理结局呈混合效果。
  • 多数纳入研究质量较差且偏倚风险数据常缺失,需高质量研究验证。

核心结论

  • 有限证据提示PBP与其他全科团队成员协作对优化老年多病共存多重用药管理结局呈混合效果,需未来高质量研究验证。

研究设计与样本

  • 系统综述检索8个电子数据库和3个试验注册库至2020年4月,纳入随机对照试验、非随机对照试验和对照前后研究。
  • 纳入标准为PBP在初级保健/全科诊所服务≥65岁同时有多病共存和多重用药患者并关注多项结局的研究。
  • 采用Cochrane RoB 1和ROBINS-I工具进行质量评价,因研究异质性采用叙述性综合。

主要发现

  • 共7项研究符合纳入标准,所有研究均采用PBP主导的药物审查并附全科医生同意实施的建议。
  • 仅1项研究描述了其他患者层面和诊所层面的干预措施。
  • 有限证据提示PBP与其他全科团队成员协作对优化药物管理结局呈混合效果。
  • 多数纳入研究质量较差,且估算偏倚风险的数据常缺失。

临床怎么用

  • 全科医生可与PBP协作开展药物审查,但当前证据尚不足以确定其对老年多病共存多重用药患者结局的稳定获益。

局限性

  • 纳入研究数量少(7项),多数质量较差,偏倚风险数据常缺失,研究间异质性大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few studies have evaluated roles of general practice-based pharmacists (PBPs), particularly in optimizing medicines management for older people with both multimorbidity and polypharmacy. OBJECTIVE: To explore the types and effectiveness of services provided by PBPs, either alone or in collaboration with other primary health care professionals, that sought to optimize medicines management for older people with multimorbidity and polypharmacy. METHODS: Eight electronic databases and three trial registries were searched for studies published in English until April 2020. Inclusion criteria were randomized controlled trials, non-randomized controlled trials and controlled before-and-after studies of services delivered by PBPs in primary care/general practice, for patients aged ≥65 years with both multimorbidity and polypharmacy that focused on a number of outcomes. The Cochrane risk of bias tool for randomized trials (RoB 1) and the Risk of Bias in Non-randomized Studies-of Interventions (ROBINS-I) assessment tool were used for quality assessment. A narrative synthesis was conducted due to study heterogeneity. RESULTS: Seven studies met inclusion criteria. All included studies employed PBP-led medication review accompanied by recommendations agreed and implemented by general practitioners. Other patient-level and practice-level interventions were described in one study. The limited available evidence suggested that PBPs, in collaboration with other practice team members, had mixed effects on outcomes focused on optimizing medicines management for older people. Most included studies were of poor quality and data to estimate the risk of bias were often missing. CONCLUSION: Future high-quality studies are needed to test the effects of PBP interventions on a well-defined range of medicines management-related outcomes. Optimizing medicines use for older people (aged ≥ 65 years) with multimorbidity (the presence of two or more long-term conditions) and polypharmacy (the concomitant use of four or more medicines) is urgent due to an ageing population which commonly has complex medications regimens. It is anticipated that pharmacists who have been integrated into general practices [also called practice-based pharmacists (PBPs)] will positively impact on patient outcomes through various roles and activities. As the role of PBPs is relatively new, little is known about the exact nature of their role and how these pharmacists will optimize medicines management for older people in a patient-centred manner. The aim of this research was to provide a detailed understanding of how PBPs may enhance optimization of medication management in older people and to study the effects of PBPs’ interventions on outcomes-focused on optimizing medicines management for older people with multimorbidity and polypharmacy such as quality of life. The seven included studies indicated that PBP-led interventions such as medication reviews improved a number of outcomes but had either a limited effect or no effect on other outcomes. Further high-quality research is needed in this area.

来源:Fam Pract,查看原文。版权归原作者所有。

引用

  1. Hasan Ibrahim AS, Barry HE, Hughes CM, et al. A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy. Fam Pract. 2021. PMID: 33506870. doi:10.1093/fampra/cmaa146

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。